Dienogest (Visanne, BAY86-5258)

DRUG4 trials

Sponsors

Bayer

Conditions

Endometriosis

Phase 2

Visanne Study to Assess Safety in Adolescents

CompletedNCT01283724

BayerEndometriosis

Start: 2011-03-31End: 2014-06-30Updated: 2015-08-13

Phase 3

Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients

CompletedNCT01822080

BayerEndometriosis

Start: 2013-03-31End: 2015-11-30Updated: 2015-11-25

Unknown Phase

Regulatory Post Marketing Surveillance Study in Korea

CompletedNCT01788722

BayerEndometriosis

Start: 2013-07-19End: 2017-08-11Updated: 2018-08-02

To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With Endometriosis

CompletedNCT02425462

BayerEndometriosis

Start: 2015-04-28End: 2018-12-14Updated: 2019-09-25

Related Papers

Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN

Reproductive Sciences2022-02-0228 citations

Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice.

2019-05-1615 citations